Who owns GYRE THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GYRE from SEC Form 13F filings across 60 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 60 institutions disclosed 8.7M shares of GYRE THERAPEUTICS, INC. worth $57.1M — about 8.6% of shares outstanding; the largest disclosed holder is HSG Holding Ltd. Source: SEC Form 13F filings, parsed by EvidInvest.
60
13F holders
$57.1M
value, 2026 filers
8.6%
of shares outstanding (8.7M sh)
11
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of GYRE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | HSG Holding LtdNEW | 3.8M | $24.7M | 2.1% | 3.7% | new |
| 2 | BlackRock, Inc. | 993,943 | $6.6M | 0.0% | 1% | +31.0% |
| 3 | Octagon Capital Advisors LPNEW | 954,416 | $6.3M | 0.6% | 0.9% | new |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 876,927 | $5.8M | 0.0% | 0.9% | -10.9% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 532,950 | $3.5M | 0.0% | 0.5% | +23.5% |
| 6 | STATE STREET CORP | 245,402 | $1.6M | 0.0% | 0.2% | +13.4% |
| 7 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 184,286 | $1.2M | 0.0% | 0.2% | +11.5% |
| 8 | NORTHERN TRUST CORP | 169,537 | $1.1M | 0.0% | 0.2% | +26.7% |
| 9 | SBI Securities Co., Ltd. | 166,750 | $1.1M | 0.0% | 0.2% | -2.4% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 151,073 | $995,571 | 0.0% | 0.2% | +9.7% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 123,953 | $816,850 | 0.0% | 0.1% | +77.5% |
| 12 | GOLDMAN SACHS GROUP INC | 86,235 | $568,289 | 0.0% | 0.1% | +17.9% |
| 13 | Bank of New York Mellon Corp | 62,750 | $413,523 | 0.0% | 0.1% | +45.4% |
| 14 | MORGAN STANLEY | 41,691 | $274,743 | 0.0% | 0% | +382.5% |
| 15 | STRS OHIO | 25,800 | $170,022 | 0.0% | 0% | +22.3% |
| 16 | DIMENSIONAL FUND ADVISORS LP | 25,268 | $166,516 | 0.0% | 0% | 0.0% |
| 17 | ALLIANCEBERNSTEIN L.P. | 24,590 | $171,392 | 0.0% | 0% | +12.6% |
| 18 | Nuveen, LLCNEW | 24,505 | $161,488 | 0.0% | 0% | new |
| 19 | UBS Group AG | 18,763 | $123,649 | 0.0% | 0% | -11.0% |
| 20 | MILLENNIUM MANAGEMENT LLCNEW | 18,488 | $121,836 | 0.0% | 0% | new |
| 21 | DEUTSCHE BANK AG\ | 17,939 | $118,218 | 0.0% | 0% | +69.0% |
| 22 | RHUMBLINE ADVISERS | 16,865 | $111,131 | 0.0% | 0% | +28.6% |
| 23 | WELLS FARGO & COMPANY/MN | 16,297 | $107,397 | 0.0% | 0% | +279.9% |
| 24 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 15,031 | $100,000 | 0.0% | 0% | new |
| 25 | FMR LLC | 14,974 | $98,679 | 0.0% | 0% | -20.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.